CRP and pulmonary arterial hypertension: Increased levels of the acute phase response protein pentraxin-3 (PTX3) were found in patients with PAH, especially CTD-PAH, vs. those of healthy controls and CTD patients without PAH, without any correlation with BNP or CRP levels, identifying PTX3 as an early marker of PAH, especially in CTDs [148].